CD14 and breast cancer: We observed higher numbers of CD141+ cDC1s and lower numbers of granulocytes (CD45+CD11b+CSF1R−CD15+CD14−) in the BM of BC patients who achieved a pathological complete response (pCR) to neoadjuvant chemotherapy (Fig. 1d, Supplementary Table 1).